Jasper Huels

739 total citations
16 papers, 566 citations indexed

About

Jasper Huels is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Jasper Huels has authored 16 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 3 papers in Pathology and Forensic Medicine and 3 papers in Physiology. Recurrent topics in Jasper Huels's work include Migraine and Headache Studies (5 papers), Bone health and osteoporosis research (3 papers) and Trigeminal Neuralgia and Treatments (3 papers). Jasper Huels is often cited by papers focused on Migraine and Headache Studies (5 papers), Bone health and osteoporosis research (3 papers) and Trigeminal Neuralgia and Treatments (3 papers). Jasper Huels collaborates with scholars based in Switzerland, United States and United Kingdom. Jasper Huels's co-authors include Stéphane A. Régnier, Melvin Olson, Jeroen P. Jansen, Gert Bergman, D van Assche, Diane Whalley, Stephen P. McKenna, Elena Peruzzi, SP McKenna and Licia Grazzi and has published in prestigious journals such as Neurology, PEDIATRICS and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Jasper Huels

16 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jasper Huels Switzerland 12 164 124 114 97 92 16 566
Amelia Santosa Singapore 12 63 0.4× 42 0.3× 17 0.1× 54 0.6× 12 0.1× 49 433
Ahmad Amin Iran 17 101 0.6× 83 0.7× 14 0.1× 35 0.4× 10 0.1× 98 742
Dorota Lewandowska Poland 11 103 0.6× 162 1.3× 26 0.2× 8 0.1× 16 0.2× 44 479
Heejin Yoo South Korea 14 163 1.0× 66 0.5× 67 0.6× 6 0.1× 14 0.2× 54 641
Frederick V. Ramsey United States 13 80 0.5× 50 0.4× 33 0.3× 31 0.3× 4 0.0× 35 524
Peter Hur United States 17 40 0.2× 33 0.3× 32 0.3× 84 0.9× 8 0.1× 48 741
Halise Akça Türkiye 11 75 0.5× 35 0.3× 35 0.3× 11 0.1× 20 0.2× 49 412
Savaş Sipahi Türkiye 13 44 0.3× 70 0.6× 16 0.1× 39 0.4× 5 0.1× 53 465
Adriana Garzaniti Italy 17 64 0.4× 46 0.4× 455 4.0× 7 0.1× 18 0.2× 32 1.3k
Silu Sun China 9 51 0.3× 312 2.5× 41 0.4× 12 0.1× 7 0.1× 28 650

Countries citing papers authored by Jasper Huels

Since Specialization
Citations

This map shows the geographic impact of Jasper Huels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasper Huels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasper Huels more than expected).

Fields of papers citing papers by Jasper Huels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasper Huels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasper Huels. The network helps show where Jasper Huels may publish in the future.

Co-authorship network of co-authors of Jasper Huels

This figure shows the co-authorship network connecting the top 25 collaborators of Jasper Huels. A scholar is included among the top collaborators of Jasper Huels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasper Huels. Jasper Huels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vo, Pamela, et al.. (2021). Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden. PharmacoEconomics. 39(3). 357–372. 21 indexed citations
2.
Schramm, Sara, et al.. (2021). Social Impact of Prophylactic Migraine Treatments in Germany: A State-Transition and Open Cohort Approach. Value in Health. 24(10). 1446–1453. 6 indexed citations
3.
Huels, Jasper, et al.. (2020). Economic evaluations in migraine: systematic literature review and a novel approach. Journal of Medical Economics. 23(8). 864–876. 13 indexed citations
4.
Newman, Lawrence C., Jasper Huels, Pamela Vo, et al.. (2020). Economic Burden Increased with Number of Treatment Failures in Migraine Patients - A Retrospective Claims Database Analysis in the United States (1485). Neurology. 94(15_supplement). 1 indexed citations
5.
Régnier, Stéphane A. & Jasper Huels. (2014). Potential impact of vaccination againstNeisseria meningitidisonNeisseria gonorrhoeaein the United States: Results from a decision-analysis model. Human Vaccines & Immunotherapeutics. 10(12). 3737–3745. 25 indexed citations
6.
Régnier, Stéphane A. & Jasper Huels. (2013). Association Between Respiratory Syncytial Virus Hospitalizations in Infants and Respiratory Sequelae. The Pediatric Infectious Disease Journal. 32(8). 820–826. 126 indexed citations
7.
Régnier, Stéphane A. & Jasper Huels. (2013). Drug versus vaccine investment: a modelled comparison of economic incentives. Cost Effectiveness and Resource Allocation. 11(1). 23–23. 10 indexed citations
8.
9.
Jansen, Jeroen P., Gert Bergman, Jasper Huels, & Melvin Olson. (2010). The Efficacy of Bisphosphonates in the Prevention of Vertebral, Hip, and Nonvertebral-Nonhip Fractures in Osteoporosis: A Network Meta-Analysis. Seminars in Arthritis and Rheumatism. 40(4). 275–284.e2. 88 indexed citations
10.
Jansen, Jeroen P., Gert Bergman, Jasper Huels, & Melvin Olson. (2009). Prevention of vertebral fractures in osteoporosis: mixed treatment comparison of bisphosphonate therapies. Current Medical Research and Opinion. 25(8). 1861–1868. 33 indexed citations
11.
Abrams, Paul, Con Kelleher, Jasper Huels, et al.. (2008). Clinical relevance of health‐related quality of life outcomes with darifenacin. British Journal of Urology. 102(2). 208–213. 21 indexed citations
12.
Olson, Melvin, et al.. (2007). POS8 COMPARISON OF THE COST-EFFECTIVENESS OF ZOLEDRONIC ACID 5 MG FORTHE MANAGEMENT OF POST-MENOPAUSAL OSTEOPOROSIS IN THE UK SETTING. Value in Health. 10(6). A395–A396. 1 indexed citations
13.
McKenna, SP, D Whalley, Y. De Prost, et al.. (2006). Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel®, SDZ ASM 981): impact on quality of life and health‐related quality of life. Journal of the European Academy of Dermatology and Venereology. 20(3). 248–254. 32 indexed citations
14.
Hawkey, Christopher J., et al.. (2004). Therapeutic Arthritis Research and Gastrointestinal Event Trial of lumiracoxib – study design and patient demographics. Alimentary Pharmacology & Therapeutics. 20(1). 51–63. 26 indexed citations
15.
Whalley, Diane, Jasper Huels, Stephen P. McKenna, & D van Assche. (2002). The Benefit of Pimecrolimus (Elidel, SDZ ASM 981) on Parents’ Quality of Life in the Treatment of Pediatric Atopic Dermatitis. PEDIATRICS. 110(6). 1133–1136. 73 indexed citations
16.
Bussone, G., Licia Grazzi, Domenico D’Amico, et al.. (1999). Acute Treatment of Migraine Attacks: Efficacy and Safety of A Nonsteroidal Anti-Inflammatory Drug, Diclofenac-Potassium, in Comparison To Oral Sumatriptan and Placebo. Cephalalgia. 19(4). 232–240. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amelia Santosa Breakdown of academic impact, for papers by Ahmad Amin Breakdown of academic impact, for papers by Dorota Lewandowska Breakdown of academic impact, for papers by Heejin Yoo Breakdown of academic impact, for papers by Frederick V. Ramsey Breakdown of academic impact, for papers by Peter Hur Breakdown of academic impact, for papers by Halise Akça Breakdown of academic impact, for papers by Savaş Sipahi Breakdown of academic impact, for papers by Adriana Garzaniti Breakdown of academic impact, for papers by Silu Sun
Rankless by CCL
2026